Puma Biotechnology Inc (PBYI)
5.03
+0.15
(+3.07%)
USD |
NASDAQ |
Apr 26, 16:00
5.03
0.00 (0.00%)
After-Hours: 20:00
Puma Biotechnology Cash from Operations (TTM): 27.01M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 27.01M |
| September 30, 2023 | 24.24M |
| June 30, 2023 | 30.88M |
| March 31, 2023 | 13.71M |
| December 31, 2022 | -15.83M |
| September 30, 2022 | -28.94M |
| June 30, 2022 | -35.71M |
| March 31, 2022 | -21.91M |
| December 31, 2021 | 20.65M |
| September 30, 2021 | 20.45M |
| June 30, 2021 | 11.67M |
| March 31, 2021 | 27.97M |
| December 31, 2020 | 0.773M |
| September 30, 2020 | 7.974M |
| June 30, 2020 | -1.053M |
| March 31, 2020 | 26.97M |
| December 31, 2019 | 22.38M |
| September 30, 2019 | 27.86M |
| June 30, 2019 | 27.90M |
| March 31, 2019 | -33.98M |
| December 31, 2018 | -24.10M |
| September 30, 2018 | -66.76M |
| June 30, 2018 | -114.41M |
| March 31, 2018 | -142.68M |
| December 31, 2017 | -172.47M |
| Date | Value |
|---|---|
| September 30, 2017 | -177.82M |
| June 30, 2017 | -157.81M |
| March 31, 2017 | -142.70M |
| December 31, 2016 | -141.69M |
| September 30, 2016 | -133.76M |
| June 30, 2016 | -135.74M |
| March 31, 2016 | -139.47M |
| December 31, 2015 | -154.47M |
| September 30, 2015 | -139.90M |
| June 30, 2015 | -127.35M |
| March 31, 2015 | -110.18M |
| December 31, 2014 | -77.20M |
| September 30, 2014 | -72.32M |
| June 30, 2014 | -60.01M |
| March 31, 2014 | -53.61M |
| December 31, 2013 | -55.05M |
| September 30, 2013 | -66.28M |
| June 30, 2013 | -61.91M |
| March 31, 2013 | -59.71M |
| December 31, 2012 | -44.01M |
| September 30, 2012 | -20.84M |
| June 30, 2012 | -13.34M |
| March 31, 2012 | -4.605M |
| December 31, 2011 | -1.824M |
| September 30, 2011 | -0.1775M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-35.71M
Minimum
Jun 2022
30.88M
Maximum
Jun 2023
9.842M
Average
20.45M
Median
Sep 2021
Cash from Operations (TTM) Benchmarks
| ADMA Biologics Inc | 8.80M |
| Pfizer Inc | 8.70B |
| Sarepta Therapeutics Inc | -500.99M |
| Immunogen Inc (DELISTED) | -197.89M |
| Regeneron Pharmaceuticals Inc | 4.594B |